Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Fellows currently holds 2,524,164 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Fellows has been a net seller of GNBT stock. They have purchased $0 and sold $150.1K worth of shares.
Stephen Fellows's most recent insider trade was on Jun 18, 2013, when they sold 2,524,164 shares at $0.04 per share.
Stephen Fellows serves as Executive at GENEREX BIOTECHNOLOGY CORP (GNBT). They have executed 4 insider transactions totaling $150.1K over their tenure at the company.
Stephen Fellows holds the position of Executive at GENEREX BIOTECHNOLOGY CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Stephen Fellows has shown a selling trading pattern, with $0 in total purchases and $150.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen Fellows was on Jun 18, 2013, when they sold $101.0K worth of GNBT shares. This transaction involved 2,524,164 shares at $0.04 per share.
Stephen Fellows currently owns 2,524,164 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Fellows's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Fellows has 4 Form 4 filings on record as an insider at GENEREX BIOTECHNOLOGY CORP.
Set alerts for Stephen Fellows and 40,000+ other insiders.